The results support the effects of ISOF via the cAMP/AQP4/SPP1/PIK3C3 axis on chronic airway inflammation, demonstrate its potential to reduce Th17 differentiation and thus the Th17/Treg balance, and provide potential targets for the treatment of this disease. This evidence concerns the gene PIK3C3 and inflammatory response.